Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

BMC Gastroenterology

Table 3 Factors for 20% increase of platelet 1-year after DAA

Variable	Odds ratio	95% CI	p
Age (years)	1.068	0.949–1.201	0.273
ALT (U/L)	1.025	1.002–1.048	0.030
γ-GTP (U/L)	1.003	0.988–1.018	0.734
Albumin (g/dL)	5.609	0.790–39.830	0.085
Total-bilirubin (mg/dL)	0.827	0.142–4.804	0.833
Creatinine (mg/dL)	0.183	0.007–5.077	0.316
White blood cells (/µL)	1.000	0.999–1.000	0.753
Platelets (× 10⁴/ µL)	0.861	0.583–1.273	0.453
AFP (ng/mL)	1.013	0.996–1.031	0.141
Fib-4 index	1.022	0.734–1.423	0.898
Splenic Index (cm²)	1.008	0.950–1.070	0.789

DAA Direct acting antiviral, CI Confidence interval, ALT Alanine amino transferase, γ-GTP γ-glutamyl transpeptidase, AFP Alpha fetoprotein

ISSN: 1471-230X